Holen Sie sich die Stockscreener-App
0.67
2.19%
-0.015
Handel nachbörslich:
.67
Schlusskurs vom Vortag:
$0.685
Offen:
$0.713
24-Stunden-Volumen:
544.19K
Relative Volume:
0.69
Marktkapitalisierung:
$31.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.58M
KGV:
-0.2528
EPS:
-2.65
Netto-Cashflow:
$-42.82M
1W Leistung:
-5.57%
1M Leistung:
-1.00%
6M Leistung:
-45.53%
1J Leistung:
-38.53%
1-Tages-Spanne:
$0.668
$0.7149
1-Wochen-Bereich:
$0.668
$0.81
52-Wochen-Spanne:
$0.6108
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Firmenname
Iterum Therapeutics Plc
Sektor
Branche
Telefon
(872) 225-6077
Adresse
3 DUBLIN LANDINGS, DUBLIN 1
Vergleichen Sie ITRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.67 | 30.59M | 0 | -35.58M | -42.82M | -2.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Herabstufung | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Multi factor analysis applied to Iterum Therapeutics plcJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Technical signs of recovery in Iterum Therapeutics plcWeekly Trade Report & Safe Capital Growth Plans - newser.com
Can Iterum Therapeutics plc stock deliver sustainable ROETreasury Yields & Daily Market Momentum Tracking - newser.com
Is Iterum Therapeutics plc stock a dividend growth opportunityRate Hike & Low Risk Investment Opportunities - newser.com
Full technical analysis of Iterum Therapeutics plc stockJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Why Iterum Therapeutics plc stock is favored by pension funds2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Volatility clustering patterns for Iterum Therapeutics plcJobs Report & Accurate Technical Buy Alerts - newser.com
Iterum Therapeutics plc stock trendline breakdownWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
Wall Street Zen Upgrades Iterum Therapeutics (NASDAQ:ITRM) to Hold - Defense World
How Iterum Therapeutics plc stock trades before earningsInflation Watch & Low Volatility Stock Recommendations - newser.com
How to interpret RSI for Iterum Therapeutics plc stockWeekly Stock Analysis & Weekly Top Gainers Trade List - newser.com
Is it time to cut losses on Iterum Therapeutics plcBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Valuation Update: Is Iterum Therapeutics plc stock risky to hold nowInflation Watch & Stepwise Trade Execution Plans - خودرو بانک
Iterum Therapeutics sees cash runway into 2026 - Yahoo Finance
Is Iterum Therapeutics plc forming a reversal patternGDP Growth & Technical Entry and Exit Alerts - newser.com
Merger Talk: How is Iterum Therapeutics plc managing supply chain issuesJuly 2025 Closing Moves & Safe Capital Growth Plans - خودرو بانک
Iterum Therapeutics launches antibiotic ORLYNVAH in targeted U.S. markets By Investing.com - Investing.com Australia
What MACD signals say about Iterum Therapeutics plc2025 Biggest Moves & AI Driven Stock Reports - newser.com
Iterum Therapeutics (ITRM) Advances Launch and Patent Innovations - GuruFocus
Iterum Therapeutics launches antibiotic ORLYNVAH in targeted U.S. markets - Investing.com
Iterum Therapeutics Provides Business Update and Launches ORLYNVAH™ to Combat Multi-Drug Resistant Infections - Quiver Quantitative
New Antibiotic ORLYNVAH Launches in US: Iterum Therapeutics Targets Multi-Drug Resistant Infections - Stock Titan
Using data tools to time your Iterum Therapeutics plc exit2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Aug Volume: Is Iterum Therapeutics plc part of any major indexMarket Movement Recap & Daily Profit Maximizing Tips - خودرو بانک
Applying Elliott Wave Theory to Iterum Therapeutics plcQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Can technical indicators confirm Iterum Therapeutics plc’s reversalJuly 2025 Levels & Low Risk Entry Point Guides - newser.com
Evaluating Iterum Therapeutics plc with trendline analysis2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Iterum Therapeutics Faces Shareholder Pushback on Key Proposals - MSN
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):